Serum metallothionein in newly diagnosed patients with childhood solid tumours
Authors | |
---|---|
Year of publication | 2010 |
Type | Article in Periodical |
Magazine / Source | Acta Biochimica Polonica |
MU Faculty or unit | |
Citation | KŘÍŽKOVÁ, Soňa, Michal MASAŘÍK, Petr MAJZLÍK, Jiří KUKAČKA, Jarmila KRUSEOVÁ, Vojtěch ADAM, Richard PRŮŠA, Tomáš ECKSCHLAGER, Marie STIBOROVÁ and René KIZEK. Serum metallothionein in newly diagnosed patients with childhood solid tumours. Acta Biochimica Polonica. Poland, 2010, vol. 57, No 4, p. 561-566. ISSN 0001-527X. |
Field | Biochemistry |
Keywords | metallothionein; cancer; serum; Brdicka reaction; marker |
Description | Tumour markers are substances produced by malignant cells or by the organism as a response to cancer development. Determination of their levels can, therefore, be used to monitor the risk, presence and prognosis of a cancer disease or to monitor the therapeutic response or early detection of residual disease.Results found in this work indicate that the MT level in blood serum can be considered as a promising marker for diagnostics, prognosis and estimation of therapy efficiency of childhood tumours. |
Related projects: |